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Abstract
Background: The quaking viable (qk
v) mice have uncompacted myelin in their central and peripheral nervous system (CNS,
PNS). The qk gene encodes 3 major alternatively spliced isoforms that contain unique sequence at their C-terminus dictating
their cellular localization. QKI-5 is a nuclear isoform, whereas QKI-6 and QKI-7 are cytoplasmic isoforms. The qk
v mice harbor
an enhancer/promoter deletion that prevents the expression of isoforms QKI-6 and QKI-7 in myelinating cells resulting in a
dysmyelination phenotype. It was shown that QKI regulates the differentiation of oligodendrocytes, the myelinating cells of
the CNS, however, little is known about the role of the QKI proteins, or RNA binding proteins in PNS myelination.
Methodology/Principal Findings: To define the role of the QKI proteins in PNS myelination, we ectopically expressed QKI-6
and QKI-7 in primary rat Schwann cell/neuron from dorsal root ganglia cocultures. We show that the QKI isoforms blocked
proliferation and promoted Schwann cell differentiation and myelination. In addition, these events were coordinated with
elevated proteins levels of p27
KIP1 and myelin basic protein (MBP), markers of Schwann cell differentiation. QKI-6 and QKI-7
expressing co-cultures contained myelinated fibers that had directionality and contained significantly thicker myelin, as
assessed by electron microscopy. Moreover, QKI-deficient Schwann cells had reduced levels of MBP, p27
KIP1 and Krox-20
mRNAs, as assessed by quantitative RT-PCR.
Conclusions/Significance: Our findings suggest that the QKI-6 and QKI-7 RNA binding proteins are positive regulators of
PNS myelination and show that the QKI RNA binding proteins play a key role in Schwann cell differentiation and
myelination.
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Introduction
The quaking (qk) viable mice (qk
v) develop rapid tremors and clonic
seizures resulting from their severe dysmyelination [1]. Qk
v mice
contain a deletion in the promoter and enhancer region of the qk
gene that prevents proper expression of its encoding proteins [2].
Three major alternatively spliced transcripts are generated from the
qkgene,encodingisoformsthatdifferintheirC-terminalaminoacid
sequence. QKI-5 contains 30 unique amino acids that harbor a
nuclear localization signal and thus QKI-5 is nuclear [3]. QKI-6
and QKI-7 contain 8 and 14 unique residues, respectively, and
these isoforms are predominantly cytoplasmic [4]. The QKI
isoforms homo- and heterodimerize [5] and their balanced
expression in oligodendrocytes is required for proper myelination
in the central nervous system (CNS) [6]. The QKI isoforms are also
expressed in Schwann cells [7], the myelinating cells of the
peripheral nervous system (PNS). The expression of QKI-5 is
highestduringembryogenesis anddeclineswith age [2]. The QKI-6
and QKI-7 isoforms are expressed during late embryogenesis and
their peak expression coincides with myelination at post-natal day
14 in mouse brain [2]. The qk promoter deletion observed in qk
v
mice mainly prevents the expression of QKI-6 and QKI-7 isoforms,
hence the balance between the isoforms is lost and QKI-5 is the
predominant isoform remaining [7]. It is thought that the lack of
QKI-6 and QKI-7 expression is the reason for oligodendrocyte
maturation defectsandthedysmyelination,observed inqk
v mice [7].
Consistent with this hypothesis, the ectopic expression of the QKI-6
and QKI-7 induces oligodendrocyte differentiation [8] and an
oligodendrocyte-specific QKI-6 transgenic allele rescues the CNS
myelination defects of the qk
v mice [9].
The QKI isoforms are members of the KH-type RNA binding
protein family that bind specific RNA sequences with high affinity
PLoS ONE | www.plosone.org 1 June 2009 | Volume 4 | Issue 6 | e5867[10,11,12]. These QKI proteins can selectively interact with a
short sequence termed the QKI response element (QRE) [13,14],
found in the 39-untranslated region (39-UTR) of the mRNAs
encoding MBP [6,15], Krox-20 (also called Egr-2) [13,16] and
MAP1B [17]. The sequence preference for QKI recognition is
NACUAAY (with a space of N1-20) UAAY, where N is any
nucleotide and Y is a pyrimidine [13]. Using the QKI RNA
binding consensus sequence, a bioinformatics analysis led to the
identification of binding sites in the p27
KIP1 (cyclin-dependent
kinase inhibitor), MBP and Krox-20 mRNAs and these sequences
were bound by the QKI proteins in vitro with high affinity using
gel-shift assays [13]. Moreover, the QKI isoforms associated with
p27
KIP1 mRNA in vivo and lead to the stabilization of the mRNA
half-life in oligodendrocytes [8]. These findings provide evidence
that the QKI proteins are regulators of post-transcriptional events
during myelination.
Schwann cells in the PNS establish close contact with axons and
produce myelin, a specialized membraneous structure that permits
rapid nerve conduction [18,19]. Neural crest-derived cells
associate with the sensory axons growing out of the dorsal root
ganglia (DRG) and with the CNS motor axons, and differentiate
into Schwann cells precursor cells. These cells proliferate during
their migration along the nerves and then escape from the cell
cycle followed by an up-regulation of transcription factors and
myelin proteins, forming compact myelin lamellae around the
peripheral nerves [18,19]. Several transcription factors are
required for cell cycle arrest and differentiation of Schwann cells,
including Krox-20 and Sox 10 [19]. The ability of Schwann cells
to stop proliferating and induce the cell cycle inhibitor p27
KIP11
has been associated with Krox-20 [20]. The zinc finger
transcription factor, Krox-20, is a master regulator essential for
PNS myelination [21]. Krox-20 null mice or hypomorphic
mutations block the myelination program at the premyelinating
stage [21,22]. The forced expression of Krox-20 results in cell
cycle arrest and the activation of genes encoding structural myelin
proteins and enzymes involved in lipid synthesis [23,24]. Krox-20
is also required for myelin maintenance as its loss in adult mice
results in severe demyelination and Schwann cell dedifferentiation
[25]. Therefore, Schwann cell myelination is constantly controlled
by both positive and negative factors [19,26].
In the PNS of the qk
v mouse, axons of sciatic nerves exhibit a
separation of intraperiod lines in the myelin sheath, and a
variation of Schmidt-Lanterman incisures [27,28,29]. Ventral root
axons display a dilation of the periaxonal space of myelinated
fibers and failure of Schwann cells to convert mesaxon membranes
to compact myelin [30,31]. These observations allow us to
hypothesize that QKI proteins might be involved in Schwann
cell myelination and differentiation. Despite the observations in
the CNS, the ability of the QKI proteins to regulate PNS
myelination is unknown. In this study we report that QKI-6 and
QKI-7 induce Schwann cell maturation, by promoting the
condensation of a thicker myelin. Moreover, QKI-deficient
Schwann cells had reduced levels of MBP, p27
KIP1 and Krox-20
mRNAs, as assessed by quantitative RT-PCR. These data
demonstrate that the QKI-6 and QKI-7 proteins are potent
regulators of PNS myelination.
Results
QKI-6 and QKI-7 promote cell cycle arrest of Schwann
cells
The quaking viable mice (qk
v) exhibit PNS dysmyelination
[27,28,29]. Moreover, the expression of the cytoplasmic QKI-6
and QKI-7 is lost in the Schwann cells of qk
v mice. These
observations suggest that QKI-6 and QKI-7 may regulate
Schwann cell differentiation [7]. To investigate the functional
significance of QKI in Schwann cells, primary rat co-cultures of
Schwann cells and neurons obtained from the dorsal root ganglia
(DRG), which reflect the in vivo context of glial cells in the
proximity of neurons [32], were transduced with adenoviruses
expressing QKI-6 or QKI-7. Each virus also encodes the green
fluorescent protein (GFP) for the microscopic monitoring of
transduction efficiency and ,95% of the Schwann cells were
transduced, as visualized by the presence of the green fluorescence
(data not shown and Figure 1). The adenovirus transduction
resulted in an ,6- to 8-fold increase in QKI-6 and QKI-7 protein
expression (Figure S1). This elevated level of QKI-6 and QKI-7
expression is similar to what is observed in mice brains during the
time of myelination in the CNS (Figure S2). In these conditions,
the proliferation of Schwann cells was inhibited by either QKI-6
or QKI-7 or both QKI-6/7 isoforms, as determined by
immunofluorescence detection of bromodeoxyuridine (BrdU)
incorporation (Figure 1A–H). A quantitative analysis from three
separate experiments to determine the percentage of BrdU-
positive Schwann cells set the rate of incorporation at ,3% and
,2% for cells transduced with QKI-6 or QKI-7 expressing
adenoviruses, respectively, and to ,20% for cells transduced with
the control vector GFP expressing adenovirus (Figure 1I). These
findings demonstrate that both QKI-6 and QKI-7 isoforms inhibit
Schwann cell proliferation.
QKI-6 and QKI-7 induce Schwann cell maturation
As the QKI-6 and QKI-7 isoforms are known to promote
oligodendrocyte maturation [8], we next examined whether these
isoforms could regulate the differentiation of myelinating Schwann
cells. The primary rat Schwann cell/DRGN co-cultures were
transduced with control (GFP), QKI-6, QKI-7 and QKI-6/7
expressing adenoviruses. Myelination was initiated by the addition
of ascorbic acid, a standard method of inducing myelination in
these co-cultures [32]. Five days later, the co-cultures were
examined for the expression of myelin basic proteins (MBP) by
immunofluorescence and confocal microscopy. QKI-6 and QKI-7
led to a significant increase in the number of myelinated axonal
segments, as compared to the GFP control cultures (Figure 2A–H).
Compared to GFP-transduced co-cultures, the MBP protein
expression was significantly increased (,3-fold) in QKI-6, QKI-
7 and QKI-6/7 transduced co-cultures, as observed by immuno-
blotting with anti-MBP antibodies and normalizing to b-actin
levels (Figure 2I). These data demonstrate that QKI-6 and QKI-7
are positive inducers of Schwann cell differentiation.
QKI-6 and QKI-7 are positive regulators of PNS
myelination
After the ascorbate treatment, the Schwann cells begin to
elongate and to ensheath the neighboring axon. We measured the
thickness of the myelin sheath on transverse sections of 5 day-old
myelinated cultures, by electron microscopy (Figure 3). The
myelin lamellae from cultures expressing QKI-6 (Figure 3C and
D) or QKI-7 (Figure 3E and F) were dense, and the combination
of QKI-6 and QKI-7 produced compact myelin with an increased
number of wraps (Figure 3G and H). The control GFP infected
cultures contained compact myelin with wraps separated by
interperiodal lines and had a g ratio of 0.73460.015 (Table 1). The
expression of the individual QKI-6 and QKI-7 did not lead to a
statistical significant increase in myelin (Table 1). On the other
hand, the expression of both QKI-6 and QKI-7 led to a significant
increase in myelin with a g ratio of 0.59960.030. However, ,21%
of the myelinated internodes displayed various abnormalities
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iodal space. These ultrastructural data confirmed the positive
regulatory role of QKI-6 and QKI-7 in PNS myelination.
QKI-6 and QKI-7 induce p27
KIP1 expression in myelinating
Schwann cells
The expression of p27
KIP1 is required for the cell cycle arrest
and differentiation of oligodendrocyte [33,34,35,36] and Schwann
cells [37,38]. As the QKI-6 and QKI-7 isoforms have been shown
to up-regulate p27
KIP1 protein levels [8], we investigated whether
the QKI isoforms regulate p27
KIP1 in myelinating Schwann cells.
The Schwann cell/DRGN cultures were transduced with QKI-6
and QKI-7 expressing adenoviruses and stained for p27
KIP1 and
MBP by indirect immunofluorescence. QKI-6, QKI-7 or the
combination of QK-6/-7 induced an increase in the number of
MBP-positive axonal segments (Figure 4, panels C, F, I, and L).
These augmentations in myelination correlated with the increased
number of p27
KIP1 positive nuclei (panels B, E, H, and K) that was
significantly higher in QKI-6/7 as compared to GFP-transduced
co-cultures (Figure 4, compare panels B and K). Interestingly, the
myelinating Schwann cells that were wrapped around axons
stained positively for p27
KIP1, demonstrating that nuclear p27
KIP1
expression is a marker of myelinating Schwann cells. Confocal
microscopy confirmed that p27
KIP1 positive Schwann cells are in
close contact with myelinated axons (Figure 4, panels M and N).
We next examined the change in p27
KIP1 protein levels by
immunoblotting with anti- p27
KIP1 antibodies. p27
KIP1 proteins
levels were increased ,1.7-fold in QKI-6, QKI-7 and QKI-6/7
expressing co-cultures in comparison to control cultures over-
expressing GFP (Figure 4, panel O). In addition, we examined the
Figure 2. QKI-6 and QKI-7 induce the expression of Schwann cell differentiation markers and enhance their maturation. Co-cultures
of Schwann cells/neurons were transduced with control adenoviruses (Adv GFP, A and B), adenoviruses encoding QKI-6 (C and D), QKI-7 (E and F), or a
combination of QKI-6/7 (G and H). Myelination was induced for 5 days with ascorbic acid and the culture stained with anti-MBP antibodies (red). (I)
Parallel cultures were lysed and analyzed by immunoblotting for MBP, and b-actin was used to ensure equal loading. The relative band intensities
quantified by densitometry are indicated below.
doi:10.1371/journal.pone.0005867.g002
Figure 1. The QKI isoforms induce Schwann cell cycle arrest. Primary Schwann cells/neuron co-cultures were infected for 48 hr with control
GFP adenovirus (A and B) and adenoviruses encoding for QKI-6 (C and D), QKI-7 (E and F), and the combination of QKI-6/7 (G and H). The green
fluorescence denotes infected cells (panels A, C, E and G). Incorporation of BrdU (16 hr pulse) was detected with an anti-BrdU antibody followed by a
goat anti-mouse conjugated to Alexa 546 (red) (B, D, F and H). Arrowheads denote the GFP positive Schwann cells that are also BrdU positive in the
controls infected with GFP-adenovirus. (I). The expression of each QKI isoform causes inhibition of Schwann cell proliferation. The graph shows the
percentage of GFP positive cells that are also BrdU positive. The proliferation was quantified from n.500 cells from three different experiments
(p,0.001, ANOVA). The error bars represent +/2 standard deviation of the mean.
doi:10.1371/journal.pone.0005867.g001
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specifically regulates Schwann cell differentiation and found no
significant change in QKI-6 and/or QKI-7 transduced cultures
(data not shown). Together these findings indicate that that QKI-6
and QKI-7 promote Schwann cell maturation by inducing
p27
KIP1 dependent cell cycle arrest.
QKI-deficient primary rat Schwann cells exhibit reduce
MBP, p27
KIP1 and Krox-20 mRNAs
To confirm the positive regulatory role of ectopically expressed
QKI-6 and QKI-7 in Schwann cell maturation, we used a
knockdown approach using RNA interference to reduce the
expression of the endogenous QKI-6 and QKI-7 isoforms. We first
verified the efficiency of siGENOME SMARTpool siRNA
targeting the rat QKI isoforms in C6 rat glioma cells. C6 glioma
cells were transfected with QKI siRNAa for 72 hrs and the
prepared cell lysates were immunoblotted with anti-QKI-6 or anti-
QKI-7 antibodies and anti-Sam68 antibodies were used as a
loading control. We observed that in comparison to control
cultures (siCtrl), both QKI-6 and QKI-7 isoforms were down-
regulated by .80% by QKI-specific siRNA (siQKI, Figure 5A).
We next reduced the levels of QKI expression in Schwann/
Figure 3. Electron microscopy of the myelin layers of the QKI-transduced Schwann cells/neurons co-cultures. Co-cultures of Schwann
cells/neurons were transduced with adenoviruses encoding GFP alone (A and B), QKI-6 (C and D), QKI-7 (E and F), combination of QKI-6 and QKI-7 (G
to J). Myelin layers were analyzed using electron microscopy. Each picture is a representative image from 30 different axons for each treatment
showing a detailed view of the myelin sheath.
doi:10.1371/journal.pone.0005867.g003
Table 1. One way analysis of variance, p,0.0001 for g ratio.
Treatment Number of measures G ratios Mean6SEM
AdGFP 7 0.73460.015
AdQKI-6 8 0.73560.023
AdQKI-7 6 0.71760.055
AdQKI-6/7 13 0.59960.030 **
Dunnett multiple comparison test, AdGFP versus AdQKI-6/7.
**p,0.01.
Co-cultures of Schwann cells/neurons were transduced with adenovirus coding
for different QKI isoforms. G ratio was determined from electron microscopy
micrographs of cross-sections of 5-day old myelinated cultures.
doi:10.1371/journal.pone.0005867.t001
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sensitive assay, quantitative RT-PCR, to monitor knockdown in
rat Schwann cells [39]. To monitor the efficiency of siRNA
delivery in the Schwann/DRGN cultures, we also included the
siGlo transfection indicator. We observed a .70% transfection
efficiency (Figure. 5B) which correlated with an ,50% reduction
in QKI isoform expression, as assessed by qRT-PCR (Figure 5C).
Interestingly, a significant reduction in MBP, p27
KIP1, and Krox-
Figure 5. QKI-6 and QKI-7 deficient Schwann cells have reduced levels of MBP, Krox-20 and p27
KIP1 mRNAs. (A) C6 rat glioma cells
were transfected with QKI-specific siGENOME SMARTpool or luciferase specific siRNAs control (siCtrl), lysed and proteins were immunoblotted for
QKI-6 and QKI-7 isoforms; Sam68 was used to ensure equal loading. The quantification by densitometric scanning is indicated below. (B) Co-cultures
of Schwann cells/neurons were transfected with siCtrl or QKI-specific siGENOME SMARTpools in combination with siGlo, a transfection indicator.
Transfection efficiency was assessed by the percentage of DAPI stained Schwann cells (blue) that incorporated siGlo (red) in the perinuclear region,
and siGlo signal was absent in non-transfected co-cultures. (C) The mRNA levels of QKI, MBP, p27
KIP1 and Krox-20 in siRNA-treated was quantified by
real-time RT-PCR. The bars depict the mean plus the standard error of the mean (error bars) from three separate experiments.
doi:10.1371/journal.pone.0005867.g005
Figure 4. QKI-6/7 transduced Schwann cells/neurons co-cultures display elevated nuclear p27
KIP1 staining and directional MBP
nerve fibers. Co-cultures of Schwann cells/neurons were transduced with adenoviruses coding for GFP (A, B and C), QKI-6 (D, E and F), QKI-7 (G, H
and I), or the combination of QKI-6 and QKI-7 (J, K and L). After infection, co-cultures were allowed to myelinate for 5 days with ascorbic acid. Cells
were immunostained with anti-p27
KIP1 antibodies (red), anti-MBP antibodies (purple) and visualized by fluorescence confocal microscopy. The green
cells denote infected Schwann cells as well as infected axons. Ectopic expression of QKI-6 (E), QKI-7 (H) and QKI-6/7 combination (K) activate the
expression of p27
KIP1 in the nucleus of Schwann cells. Schwann cells are in the vicinity of MBP+ axons fibers (F, I and L). The inset (L) is an image
showing a merge from p27
KIP1-positive Schwann cells and MBP-positive axons (arrowheads). (M) This image shows the double staining for p27
KIP1
(red) and MBP (purple) from a combined infection by QKI-6 and QKI-7 adenoviruses and demonstrate that p27
KIP1 Schwann cells are associated with
MBP-positive axonal internodes (arrows). (N) Denotes the green fluorescence of the GFP-positive cells of panel M. (O) Schwann/DRGN co-cultures
infected with control or the indicated QKI adenoviruses were lysed and the proteins analyzed by immunoblotting for p27
KIP1 and b-actin to ensure
equal loading. The relative band intensities quantified by densitometry are indicated below.
doi:10.1371/journal.pone.0005867.g004
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phosphate dehydrogenase) was observed (Figure 5C). Together
these data further suggest that the QKI isoforms are essential
regulators of Schwann cell myelination.
Discussion
In this report we present evidence that the QKI proteins are
determinants of Schwann cell differentiation. First we show that
the expression of QKI-6 and QKI-7 positively regulates Schwann
cell differentiation, as they promote cell cycle arrest by inducing
p27
KIP1 expression. This is further confirmed by the increased
ability of QKI-6 and QKI-7-transduced Schwann cells to produce
MBP and myelinate axons of DRGN in primary cultures.
Furthermore, in QKI-deficient Schwann cells we observe down-
regulation of the level of MBP mRNA as well as other Schwann
cell maturation markers, p27
KIP1 and Krox-20. Our findings show
that both QKI-6 and QKI-7 potentiate Schwann cell myelination,
and they exert synergistic effects when combined.
The role of RNA binding proteins or the post-transcriptional
events regulating peripheral myelination is unknown [1]. We
showed previously that QKI-6 and QKI-7 are positive regulators of
oligodendrocyte differentiation and myelin production [8]. We now
extend these finding showing a role in peripheral myelination by
Schwann cells. The visualization of the myelin sheath by electron
microscopy permitted a close examination of the myelin sheath
structure. The myelin sheaths from the QKI-6 and QKI-7
transduced co-cultures were significantly thicker, but occasional
aberrations such as cytoplasmic inclusions were observed. The
reason for the appearance of the occasional aberrations is unknown,
however, we suspect that this may be caused by continuous
expression of the QKI-6 and QKI-7 isoforms in our expression
system. These findings imply that the absence of QKI-6 and QKI-7
in the qk
v mice may be the main cause of the myelination defects
seen in the peripheral nerves of these mice.
The QKI proteins are phosphoproteins often referred to as
STAR (signal transductionand activationof RNA) proteins [11,12].
Indeed QKI is a known substrate of the soluble tyrosine kinase
p59
fyn and its phosphorylation negatively regulates its association
with RNA [40]. These observations suggest that the balance
between the nuclear and cytoplasmic QKI isoforms and/or the
QKIRNAbindingactivity maybe regulatedbysignalingpathways.
The peripheral myelination induced by the ectopic expression
of QKI-6 and QKI-7 coincided with the elevated protein
expression of p27
KIP1and MBP. The differentiation of oligoden-
drocytes requires their withdrawal from the cell cycle, and the
accumulation of p27
KIP1 precedes oligodendrocyte differentiation
[33,36,41]. Moreover, the migratory and differentiation capabil-
ities of glial progenitors are perturbed during E13 to E19 in
p27
KIP1 null mice, as there were significant increases in QKI-
positive; BrdU-positive cells in the subventricular zone compared
to wild-type controls [42]. In addition, reduction in MBP staining
is observed in p27
KIP1 knockout mice in the optic nerve, consistent
with the requirement for p27
KIP1 and PNS myelination [43]. We
have previously showed that p27
KIP1 increases after the ectopic
expression of QKI-6/7 in oligodendrocytes [8]. Moreover, the
p27
KIP1 mRNA is stabilized and a QRE is localized within the
coding region of p27
KIP1 and bound by QKI [13]. In the present
manuscript, we show that the QKI-6/7 expression in Schwann
cells results in increased myelination and nuclear p27
KIP1
expression. On the contrary, repressing QKI expression using
RNA interference resulted in suppression of its target mRNAs
including p27
KIP1, possibly by rendering the unbound p27
KIP1
mRNA susceptible to degradation. These findings suggest that
p27
KIP1 is a positive marker of PNS myelination and that QKI is
upstream of p27
KIP1 in both the CNS and PNS.
In addition to p27
KIP1, Krox-20 is another major positive
regulator of Schwann cell maturation. The production of Krox-20
mRNA is known to occur within 1 hr of contact with an axon or
after growth factor stimulation hence its alternative name early
growth factor (Egr2) [44]. It has been demonstrated that
peripheral nerves from Krox20-deficient mice are characterized
by arrested myelination and decreased myelin protein levels
[21,22]. The post-transcriptional events regulating Krox-20 are
unknown, but the Krox-20 mRNA harbors a perfect QRE that is
bound by QKI in vitro [13]. In Krox-20 null mice, the immature
Schwann cells are able to form a one-to-one relationship with
axons. The defect underlies within the inability of Schwann cells to
become arrested prior to differentiation, and their low levels of
MBP expression [21,45]. The qk-deficient mice die at E9.5 and
have an open neural tube, thus neuronal and glial cell fate
information could not be obtained from these animals [46]. The
neural tube defect is similar as that exhibited by the Krox-20 null
mice [47]. Furthermore, forced expression of Krox-20 in Schwann
cells causes a block in Schwann cell proliferation [23], as observed
with the QKI-6 and QKI-7 (Figure 1), suggesting that the QKI
proteins might be linked to Krox-20 regulation or vice versa.
Although the timing of QKI overexpression in myelinating
Schwann/DRGN cocultures did not allow us to detect a
significant Krox-20 induction, we observed a reduction in Krox-
20 transcript in QKI-deficient Schwann cells. Thus it is tempting
to speculate that QKI stabilizes Krox-20 mRNA similarly to
p27
KIP1, thus ensuring sufficient transcripts were accumulated in
Schwann cells prior to the onset of myelination. If the relationship
between Krox-20 and QKI is indeed correct, then human
peripheral neuropathies may harbor mutations within the qk gene.
Inconclusion,wehave shownthattheectopicexpression ofQKI-
6 and QKI-7 isoforms promotes Schwann cell maturation and
myelination, as assessed by MBP expression. Interestingly the
myelinating Schwann cells contained nuclear p27
KIP1 suggesting
that p27
KIP1 is a marker of myelinating Schwann cells. Our findings
show decreased levels of MBP, p27
KIP1 as well as Krox-20 mRNAs
in QKI-deficient Schwann cells. Our findings reveal that the QKI
proteins are potent inducers of Schwann cell differentiation and
strategiestoup-regulate orover-expressQKI-6and QKI-7isoforms
may be useful to enhance peripheral nerve myelination.
Materials and Methods
Primary co-cultures of Schwann cells/neurons from rat
dorsal root ganglion (DRG)
Schwann cells/neurons co-cultures were prepared using meth-
ods described previously [48]. DRGs were obtained from Sprague-
Dawley rat embryos at 15–16 days gestation from Charles River
Laboratories (St. Constant, QC, Canada). Embryos were collected
in Leibovitz’s (L-15) medium, the spinal column was dissected
from each embryo and DRGs were plucked from the spinal cords
and collected in fresh L-15 medium. DRGs were dissociated with
trypsin (0.025 % in Hank’s BSS) at 37uC for 15 min, followed by
treatment with soybean trypsin inhibitor (5 mg/ml in L-15). The
dissociated cells were resuspended for plating in defined medium
consisting of DMEM/F12 containing N1 supplement, 0.09%
BSA, 12 ng/ml 2.5 S NGF and antibiotics (penicillin/streptomy-
cin) and cells from 72 DRGs were plated onto each rat tail
collagen-coated 24-well plates. Cell cultures were maintained in
serum-free N1 medium until their use after 21 days in culture.
Myelination was initiated by adding fresh media containing
50 mg/ml of ascorbic acid. At the same time, co-cultures were
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[6]. Five days after infections, cells were used for immunostaining
experiments and/or immunoblot experiments. In each adenovirus
treatment, 3 different wells were used by experiment. Antibodies
used were for MBPs (Rabbit anti-MBP; 1:500), p27
KIP1 (Mouse
anti-p27, 1:1000, Chemicon) and for b2actin (Mouse anti-b-actin,
1:500, Chemicon). Goat anti-mouse and goat anti-rabbit second-
ary antibodies conjugated to Alex546 (Molecular Probe) and Cy5
(Jackson Immunoresearch) were used for double-labeling experi-
ments. Confocal analysis was carried out on a Zeiss microscope.
The experimental protocol for preparation of primary cell cultures
was approved by the McGill University Animal Care Committee
and meets the guidelines of the Canadian Council on Animal
Care.
Adenovirus Construction and Infection
The co-cultures were infected with the indicated adenovirus co-
expressing QKI-6 and QKI-7 driven by the TR5 (Tet-Off)
promoter and GFP is under the control of the CMV promoter as
described previously [4]. A multiplicity of infection (MOI) of 50
was sufficient to infect ,90% of the cells, as judged by GFP
positive cells.
Electron Microscopy
Adenoviruses treated co-culture were rinsed in PBS, fixed in
2.5% glutaraldehyde in 15mM sodium cacodylate (pH 7.4) for
60 min, and postfixed for 1 hr in 1% osmium tetroxide and
embedded for EM. Ultrathin sections were cut with a diamond
knife and stained with uranyl acetate and examined by
transmission electron microscopy (McGill University, Anatomy
and Cell biology department). A myelin layers analysis was
conducted on a population of 30 axons by treatment from 3
replicates experimental sets. The g-ratio was calculated by dividing
the axonal diameter by the total fiber diameter. The statistical
significance of myelin lamellae for each QKI adenoviruses
treatment versus the control AdGFP was determined by two-
sample t test ANOVA for assumption test and Tukey-Kramer
Multiple Comparisons Test for P value of 0.001. InStat3 software
(GraphPad Inc.) was used for graph and statistic analysis. (Define
G ratio used and its meaning).
Bromodeoxyuridine incorporation and cell cycle analysis
For analysis of BrdU incorporation using immunofluorescence
staining, coculture containing Schwann cells and DRG neurons
cells were infected for 24 h with adenoviruses (m.o.i: 50)
expressing the different QK isoforms or GFP control. Culture
progenitors were given a 16 h pulse with 10 mM of 5-bromo-29-
deoxyuridine (BrdU) and then fixed in 4% paraformaldehyde.
Cells were permeabilized with ice cold acetone/methanol (1:1).
After 30 min in 1N HCl and neutralization with sodium borate
buffer, cells were incubated with monoclonal anti-BrdU antibody
(1:100, Chemicon International) in PBS + 0.1%Triton + 5% goat
serum for 3 hours. A Rabbit anti-mouse Alexa 546 (Molecular
Probes) antibody diluted 1:1000 in PBS; 0.1% Triton was used for
detection.
RNAi and Transfections
QKI-specific siGENOME SMARTpool siRNA purchased from
Dharmacon (M115062-00-0010), and luciferase specific control
siRNA (CGUACGCGGAAUACUUGA) were prepared accord-
ing to manufacturer’s instructions. 100nM of each siRNA plus
50nM of siGlo indicator (Dharmacon) were delivered to each well
of a 24-well plate containing day-21 Schwann cell/DRGN co-
cultures using Lipofectamine RNAiMAX. The transfection was
repeated once every two days for three times, and cells were
harvested on day-28 of culture. Monolayer of C6 rat glioma cells
were transfected for 72 hours using conditions above.
Quantitative real-time PCR
Total RNA was harvested using the RNeasy Plus Minikit
(Qiagen) and reverse transcribed with Super Script II Reverse
Transcriptase (Invitrogen). Intron-spanning pre-designed primers
purchased from Qiagen were used at concentrations specified by
the manufacturer. Quantitative PCR was performed using
Quantitect SYBR Green qPCR kit (Qiagen) on Applied Biosystem
7500 real-time PCR system. The relative expression values for
each gene of interest normalized to glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) were analyzed by ABI SDS software
using the comparative CT method.
Supporting Information
Figure S1 QKI encoding adenovirus effectively produces QKI-6
and QKI-7 in Schwann cells (A) Primary Schwann cell/neuron
co-cultures were infected for 4 days with control GFP adenovirus
(Adv GFP), or the combination adenoviruses encoding myc-tagged
QKI-6 or QKI-7 (Adv QKI-6/7). Cultures were lysed, and
proteins were immunoblotted for QKI-6 and QKI-7 to reveal the
endogenous and the recombinant respective QKI isoforms. Both a
short exposure of 10 sec and a longer exposure 10 min is shown.
The myc-epitope tag was used to evaluate the relative levels of the
each recombinant QKI isoform in infected cultures and Sam68
was used to ensure equal loading. The molecular mass markers are
shown on the left in kDa and migration of the myc-epitope tagged
QKI (myc-QKI) and the endogenous QKI (QKI) isoforms is
shown. (B) The over-expression of recombinant QKI isoforms was
quantified by densitometric analysis compared to the endogenous
levels in arbitrary units (AU).
Found at: doi:10.1371/journal.pone.0005867.s001 (2.48 MB TIF)
Figure S2 Expression of the QKI isoforms in the mouse brains
during development. (A) Mouse brains were harvested on
embryonic day 17.5, 18.5 (E17.5, E18.5) and postnatal day 1, 3,
6, 8, 10, 15, 30 (P1–P30), homogenized and lysed. Protein lysates
were immunoblotted for QKI-5, QKI-6 and QKI-7 as indicated.
b-actin was used to ensure equal loading. (B) The expression levels
of each QKI isoform normalized to loading control was quantified
by densitometry analysis.
Found at: doi:10.1371/journal.pone.0005867.s002 (5.48 MB TIF)
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